Zilver PTX Post-Market Surveillance Study of Bare Metal Stents for Treating Femoropopliteal Artery Disease in Japan
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cook Medical
- 29 Mar 2018 Status changed from active, no longer recruiting to completed.
- 03 Nov 2015 According to a media release, data from this study were presented at the Vascular InterVentional Advances (VIVA 15) conference.
- 22 Jul 2015 Planned End Date changed from 1 May 2017 to 1 Jan 2018 as reported by ClinicalTrials.gov.